The Latest Breaking News from FDA

Philip Morris CEO Jacek Olczak made some recent interesting comments.

This CEO is going to against the better judgment of the FDA to remain youthful.

The Centres for Disease Control and Prevention (CDC) confirmed the number of patients treated for the drug-resistant strain of Pseudomonas aeruginosa has now risen to 81 patients in 18 states

The FDA will likely reject Intercept Pharmaceuticals' highly watched liver disease treatment, analysts said Monday as ICPT stock crashed.

The FDA-licensed drug could be approved for use in the UK by the end of the year

The FDA’s updated food code, restaurants should have signs saying dogs are welcome and should develop plans to handle dogs and their waste. They should provide separate food bowls so dogs don’t use plates or utensils meant for humans.

Intentionally deadly bugs and toxins and misinformation are some key fears.

With abortion increasingly restricted in many states, Sen. Patty Murray (D-Wash.), hopes to persuade Republicans to back insurance coverage for over-the-counter birth control.

Millions of patients and their caregivers breathed a collective sigh of relief when drugmaker Eli Lilly recently announced its new experimental Alzheimer’s medication appears to slow cognitive decline by 35%. The Food and Drug Administration could approve the new treatment, donanemab, as soon as this year.